Search company, investor...

Predict your next investment

Private Equity
newrhein.com

See what CB Insights has to offer

Investments

9

Portfolio Exits

3

Funds

1

About New Rhein Healthcare

New Rhein is a private equity investment firm focused on healthcare therapeutics and medical devices. Its partners and associates are former industry executives with operational and transactional experience. New Rhein invests in businesses which utilize proven products in new applications (e.g., new indications, new dosage forms, 505(b2)). The company compiles syndicates of operational focused investors who together bring a wealth of experience and a broad network of relationships to support its portfolio companies in development, regulatory, reimbursement, marketing and/or contract manufacturing. New Rhein provides an understanding on what would be attractive to strategic partners and works backwards to help its portfolio companies build their value proposition. Prior New Rhein investments have included ophthalmic pharmaceuticals, molecular diagnostics and respiratory drug/device inhalers.

Headquarters Location

77 W. Wacker Drive Suite 700

Chicago, Illinois, 60601,

United States

312-899-7942

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest New Rhein Healthcare News

Theranica Raises $45M in Series C Funding

Aug 29, 2022

Theranica, a Netanya, Israel- and Montclair, NJ-based prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other idiopathic pain conditions, closed its Series C funding round, with a first closing of $45m. The round was led by New Rhein Healthcare Investors, with participation from existing investors aMoon, Lightspeed Venture Partners, LionBird, Takoa Invest, and Corundum Open Innovation. The […] The post Theranica Raises $45M in Series C Funding appeared first on FinSMEs.

New Rhein Healthcare Investments

9 Investments

New Rhein Healthcare has made 9 investments. Their latest investment was in Theranica as part of their Series C on August 8, 2022.

CBI Logo

New Rhein Healthcare Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/29/2022

Series C

Theranica

$45M

Yes

2

10/6/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

9/24/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/19/2018

Series A

Subscribe to see more

$99M

Subscribe to see more

10

9/6/2017

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/29/2022

10/6/2020

9/24/2020

12/19/2018

9/6/2017

Round

Series C

Series B

Series A

Series A

Seed VC

Company

Theranica

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$45M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

10

10

New Rhein Healthcare Portfolio Exits

3 Portfolio Exits

New Rhein Healthcare has 3 portfolio exits. Their latest portfolio exit was Softhale on March 23, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/23/2021

Shareholder Liquidity

Softhale

$99M

4

11/22/2016

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

4/27/2015

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/23/2021

11/22/2016

4/27/2015

Exit

Shareholder Liquidity

Acquired

IPO

Companies

Softhale

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

4

10

10

New Rhein Healthcare Fund History

1 Fund History

New Rhein Healthcare has 1 fund, including New Rhein Healthcare Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/19/2018

New Rhein Healthcare Fund I

Industry Focused

Open

$47.7M

1

Closing Date

12/19/2018

Fund

New Rhein Healthcare Fund I

Fund Type

Industry Focused

Status

Open

Amount

$47.7M

Sources

1

New Rhein Healthcare Team

1 Team Member

New Rhein Healthcare has 1 team member, including current Founder, Greg Parekh.

Name

Work History

Title

Status

Greg Parekh

Biocartis, Novartis, Deutsche Bank, and Bear Stearns

Founder

Current

Name

Greg Parekh

Work History

Biocartis, Novartis, Deutsche Bank, and Bear Stearns

Title

Founder

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.